论文部分内容阅读
我们应用CA_(19-9)放免试剂盒对我院及部分外院消化道肿瘤病人进行测定,以探讨其对消化道肿瘤的诊断价值及术后疗效评估,并对部分病人术后进行随访,现报道如下。 材料和方法 一、对象: （一）正常对照组:30例（男21,女9）,平均年龄27.5±5.6岁。 （二）胃癌组:20例（男12,女8）,平均年龄42.5±17.5岁。 （三）结直肠癌组:21例（男15,女6）,平均年龄52.6±13.4岁。 （四）胰腺癌组:12例（男8,女4）,平均年龄55.9±13.6岁。 （五）胆囊、胆管癌组:9例（男3,女6）,平均年龄49.5±21.2岁。 以上肿瘤组病人均经手术及病理证实。 二、方法: （一）CA_(19-9)放免试剂盒由天津新传公司提供,按说明书操作。 （二）各组病人均抽血测定CA_(19-9)值。手术病人手术后一个月再次测定,术后随访病人,每隔三个月测定一次CA_(19-9)值。
We used the CA 19-9 radioimmunoassay kit to measure patients with digestive tract cancer in our hospital and some other hospitals in order to explore its diagnostic value and postoperative curative effect evaluation of gastrointestinal cancer, and follow-up of some patients after surgery. The report is as follows. Materials and Methods 1. Object: (a) Normal control group: 30 patients (male 21, female 9), mean age 27.5 ± 5.6 years old. (b) Gastric cancer group: 20 cases (male 12, female 8), mean age 42.5±17.5 years old. (C) Colorectal cancer group: 21 cases (male 15, female 6), mean age 52.6±13.4 years old. (D) Pancreatic cancer group: 12 cases (male 8, female 4), mean age 55.9±13.6 years old. (5) Gallbladder and bile duct cancer group: 9 cases (male 3, female 6) with an average age of 49.5±21.2 years old. All patients in the above tumor group were confirmed by surgery and pathology. Second, methods: (A) CA_(19-9) radioimmunoassay kit provided by Tianjin New Pass, according to the instructions. (b) All patients were drawn to determine the CA 19-9 value. The surgical patient was measured again one month after the operation. The patient was followed up and the CA 19-9 value was measured every three months.